Cytokinetics Inc (CYTK)

(19% Negative) Cytokinetics, Incorporated (CYTK) Announces Delay in Specified Development Timeline Due to Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Scholar Rock Holding Corp (SRRK)

(90% Positive) Scholar Rock Holding Corporation (SRRK) Announces Enrollment Update for apitegromab Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment